For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
The current state of pharmaceutical tariffs
Background Amid the Trump trade upheaval, pharmaceutical products receive different treatment than many other US imports. Pharmaceuticals are treated differently for reasons such as their…
DC Journal
Point: Medicaid Work Requirements Are a Common-Sense Reform
Medicaid is the government program that is supposed to help the poor afford health care. Its cost to taxpayers has skyrocketed in the last few…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Search Posts
City Journal
A Pox By Any Other Name
Anyone wondering why medical authorities seem so ineffectual need look no further than their newfound obsession with renaming the monkeypox virus and the disease it…
National Review
Monkeypox Outbreak Leveling Off, No Thanks to Government
Something that apparently surprised government bureaucrats and left-wing commentators but is, in fact, completely predictable is happening: The growth in new monkeypox cases is leveling off…
The New York Post
Key to CDC reform is undoing mission creep — and tossing woke programs
Centers for Disease Control and Prevention Director Rochelle Walensky has finally admitted what has been obvious to most observers for 2½ years: The agency has been…
C-SPAN
Video: Senior Fellow Joel Zinberg Joins C-SPAN to Discuss Senate Democratic Health Care and Prescription Drug Proposals
Senior Fellow Joel Zinberg joined the Washington Journal to discuss Senate Democratic Health Care and Prescription Drug Proposals. Click here to read more.
City Journal
No More Masks
Covid-19 cases are on the rise again in the United States. Even President Biden is infected. But the biggest danger is not the virus—the now-dominant…
National Review
Regulators’ Misguided Crackdown on Nicotine Products and Their Makers
Federal agencies must really love black markets. Last week, the Food and Drug Administration (FDA) announced a plan to limit nicotine in cigarettes and …
